ProKidney logo

ProKidney

PROK | NASDAQ
Chart Builder DCF Calculator
$1.04
$0.00 (-0.48%)
At close: Nov 16, 2026, 4:00 PM ET
$1.07
+$0.03 (+2.88%)
After-hours: Nov 16, 2026, 7:30 PM ET
-0.48%

Rating

Updated: Nov 16, 2026
34.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #671/1021 (Top 66%)

Key Statistics

Market Data

Market Cap $349.7M
1D Range
1.01 1.10
52W Range
1.01 2.57

Valuation (TTM)

PE -1.73
PB 1.98
EV/EBITDA -1.19

Valuation (NTM)

Forward PE N/A
Forward PEG 0.04
Price Target $5.00
Loading financial charts...

Profile

ProKidney Corp. is a biotechnology firm currently in the clinical trial phase, specializing in the development of innovative cell-based treatments. Their flagship product is Renal Autologous Cell Ther...

Sector Healthcare
Industry Biotechnology
Employees 231
IPO Date Jun 30, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 12, 2026
EPS
-$0.17
Miss -6.39%
REV
$174K
Beat +39.65%
Next Earnings
Mar 17, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$5.00
Upside
+380.77%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.